| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 10 1345-1351, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
G Peterson and S Barnes
Department of Pharmacology and Toxicology, University of Alabama at Birmingham 35294, USA.
Genistein is a naturally occurring dietary protein tyrosine kinase (PTK) inhibitor that is hypothesized to be responsible for the lower rate of breast cancer observed in Asian women consuming soy. Although genistein is a potent in vitro PTK inhibitor, its mechanism of action in vivo is not known. In vivo, breast cancer growth is regulated by estrogens and peptide growth factors, such as epidermal growth factor (EGF), the receptor of which has intrinsic PTK activity. Therefore, genistein may block mammary epithelial cell growth by interfering with signal transduction events stimulated by estradiol or growth factors. The effect of genistein, related isoflavones, and other tyrosine kinase inhibitors on fetal bovine serum-, estradiol-, and EGF-stimulated cell growth and signal transduction pathways was examined in five human breast cancer cell lines. Genistein inhibited the growth of these cells by each of the growth stimuli with IC50 values ranging from 2.6 to over 20 micrograms/ml. Growth inhibition by genistein was cytostatic and reversible at IC50 concentrations. Related isoflavones were less potent growth inhibitors than genistein, whereas the synthetic PTK inhibitor tyrphostin A25 was an equally potent growth inhibitor. The mechanism of genistein growth inhibition in human breast cancer cells did not depend on the presence of functional estrogen receptor signaling pathways or on inhibition of EGF-receptor PTK activity. Furthermore, genistein (< or = 20 micrograms/ml) did not decrease constitutive or EGF-induced tyrosine phosphorylation as determined by Western blotting with antiphosphotyrosine antibodies. These data suggest that although genistein inhibits the growth of breast cancer cells in culture, it does so without gross inhibition of PTK activity.
This article has been cited by other articles:
![]() |
D. Liu, W. Zhen, Z. Yang, J. D. Carter, H. Si, and K. A. Reynolds Genistein Acutely Stimulates Insulin Secretion in Pancreatic {beta}-Cells Through a cAMP-Dependent Protein Kinase Pathway. Diabetes, April 1, 2006; 55(4): 1043 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liu, H. Jiang, and R. W. Grange Genistein Activates the 3',5'-Cyclic Adenosine Monophosphate Signaling Pathway in Vascular Endothelial Cells and Protects Endothelial Barrier Function Endocrinology, March 1, 2005; 146(3): 1312 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liu, L. L. Homan, and J. S. Dillon Genistein Acutely Stimulates Nitric Oxide Synthesis in Vascular Endothelial Cells by a Cyclic Adenosine 5'-Monophosphate-Dependent Mechanism Endocrinology, December 1, 2004; 145(12): 5532 - 5539. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Norman, R. R. Butrum, E. Feldman, D. Heber, D. Nixon, M. F. Picciano, R. Rivlin, A. Simopoulos, M. J. Wargovich, E. K. Weisburger, et al. The Role of Dietary Supplements during Cancer Therapy J. Nutr., November 1, 2003; 133(11): 3794S - 3799. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. A. Kayisli, C. A. H. Aksu, M. Berkkanoglu, and A. Arici Estrogenicity of Isoflavones on Human Endometrial Stromal and Glandular Cells J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5539 - 5544. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. I. Block, A. Constantinou, L. Hilakivi-Clarke, C. Hughes, D. Tripathy, J. A. Tice, K. Block, and K. Block Point-Counterpoint: Soy Intake for Breast Cancer Patients Integr Cancer Ther, March 1, 2002; 1(1): 90 - 100. [PDF] |
||||
![]() |
M. J. Messina and C. L. Loprinzi Soy for Breast Cancer Survivors: A Critical Review of the Literature J. Nutr., November 1, 2001; 131(11): 3095S - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. O. Shu, F. Jin, Q. Dai, W. Wen, J. D. Potter, L. H. Kushi, Z. Ruan, Y.-T. Gao, and W. Zheng Soyfood Intake during Adolescence and Subsequent Risk of Breast Cancer among Chinese Women Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 483 - 488. [Abstract] [Full Text] |
||||
![]() |
J. Brown, T. Byers, K. Thompson, B. Eldridge, C. Doyle, A. M. Williams, and American Cancer Society Workgroup on Nutrition and Nutrition During and After Cancer Treatment: A Guide for Informed Choices by Cancer Survivors CA Cancer J Clin, May 1, 2001; 51(3): 153 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Feng, P. Webb, P. Nguyen, X. Liu, J. Li, M. Karin, and P. J. Kushner Potentiation of Estrogen Receptor Activation Function 1 (AF-1) by Src/JNK through a Serine 118-Independent Pathway Mol. Endocrinol., January 1, 2001; 15(1): 32 - 45. [Abstract] [Full Text] |
||||
![]() |
S. Tamir, M. Eizenberg, D. Somjen, N. Stern, R. Shelach, A. Kaye, and J. Vaya Estrogenic and Antiproliferative Properties of Glabridin from Licorice in Human Breast Cancer Cells Cancer Res., October 1, 2000; 60(20): 5704 - 5709. [Abstract] [Full Text] |
||||
![]() |
R. E. Favoni and A. De Cupis The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach Pharmacol. Rev., June 1, 2000; 52(2): 179 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wroblewski Lissin and J. P. Cooke Phytoestrogens and cardiovascular health J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1403 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barnes, H. Kim, V. Darley-Usmar, R. Patel, J. Xu, B. Boersma, and M. Luo Beyond ER{alpha} and ER{beta}: Estrogen Receptor Binding Is Only Part of the Isoflavone Story J. Nutr., March 1, 2000; 130(3): 656 - 656. [Full Text] |
||||
![]() |
M. J Messina Legumes and soybeans: overview of their nutritional profiles and health effects Am. J. Clinical Nutrition, September 1, 1999; 70(3): 439S - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Hunter, L. C. Hodges, P. M. Vonier, R. Fuchs-Young, M. M. Gottardis, and C. L. Walker Estrogen Receptor Activation via Activation Function 2 Predicts Agonism of Xenoestrogens in Normal and Neoplastic Cells of the Uterine Myometrium Cancer Res., July 1, 1999; 59(13): 3090 - 3099. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ji, G. M. Willis, G. R. Frank, S. G. Cornelius, and M. E. Spurlock Soybean Isoflavones, Genistein and Genistin, Inhibit Rat Myoblast Proliferation, Fusion and Myotube Protein Synthesis J. Nutr., July 1, 1999; 129(7): 1291 - 1297. [Abstract] [Full Text] |
||||
![]() |
D. M. Tham, C. D. Gardner, and W. L. Haskell Potential Health Benefits of Dietary Phytoestrogens: A Review of the Clinical, Epidemiological, and Mechanistic Evidence J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2223 - 2235. [Abstract] [Full Text] |
||||
![]() |
J. Sfakianos, L. Coward, M. Kirk, and S. Barnes Intestinal Uptake and Biliary Excretion of the Isoflavone Genistein in Rats J. Nutr., July 1, 1997; 127(7): 1260 - 1268. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |